VEGFA and age-related macular degeneration: Anti-(vascular endothelial growth factor) VEGF therapy has made important progress in treating the wet form of AMD by targeting the abnormally formed blood vessels, but these patients still exhibit a progression of the disease and do not regain vision despite treatments.